Literature DB >> 11711299

Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.

C Marrano1, P de Macédo, P Gagnon, D Lapierre, C Gravel, J W Keillor.   

Abstract

Herein we report the synthesis and evaluation of 14 novel peptides as potential irreversible inactivators of guinea pig liver transglutaminase (TGase). These peptides were designed to resemble Cbz-L-Gln-Gly, known to be a good TGase substrate, and to include a 1,2,4-thiadiazole group. The side chain length of the amino acid residue bearing the inhibitor group was also varied in order to permit investigation of this effect. Their inactivation rate constants were measured using a direct continuous spectrophotometric method and were found to vary between 0.330 to 0.89 microM(-1) min(-1).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711299     DOI: 10.1016/s0968-0896(01)00228-0

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

Review 1.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

2.  Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.

Authors:  R Edward Watts; Mathew Siegel; Chaitan Khosla
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

Review 3.  Novel therapies for coeliac disease.

Authors:  L M Sollid; C Khosla
Journal:  J Intern Med       Date:  2011-06       Impact factor: 8.989

4.  Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors.

Authors:  Alana M M Rangaswamy; Pauline Navals; Eric W J Gates; Sammir Shad; Sarah K I Watt; Jeffrey W Keillor
Journal:  RSC Med Chem       Date:  2022-01-26

5.  Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

Authors:  Matthew Siegel; Jiang Xia; Chaitan Khosla
Journal:  Bioorg Med Chem       Date:  2007-06-13       Impact factor: 3.641

Review 6.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

7.  SUZUKI-MIYAURA COUPLING REACTIONS OF 3,5-DICHLORO-1,2,4-THIADIAZOLE.

Authors:  Abdelbasset A Farahat; David W Boykin
Journal:  Heterocycles       Date:  2012-08-21       Impact factor: 0.831

8.  Transglutaminase activation in neurodegenerative diseases.

Authors:  Thomas M Jeitner; Nancy A Muma; Kevin P Battaile; Arthur Jl Cooper
Journal:  Future Neurol       Date:  2009-07-01

9.  PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

Authors:  Jayme L Dahlin; J Willem M Nissink; Jessica M Strasser; Subhashree Francis; LeeAnn Higgins; Hui Zhou; Zhiguo Zhang; Michael A Walters
Journal:  J Med Chem       Date:  2015-02-21       Impact factor: 8.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.